- Home
- Publications
- Publication Search
- Publication Details
Title
HER2 as a target in invasive urothelial carcinoma
Authors
Keywords
-
Journal
Cancer Medicine
Volume 4, Issue 6, Pages 844-852
Publisher
Wiley
Online
2015-02-27
DOI
10.1002/cam4.432
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
- (2013) J. S. Ross et al. CLINICAL CANCER RESEARCH
- Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer
- (2013) Gopa Iyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy
- (2013) Jeffrey S Ross et al. MODERN PATHOLOGY
- Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
- (2013) Guangwu Guo et al. NATURE GENETICS
- Recent advances in novel targeted therapies for HER2-positive breast cancer
- (2012) Conleth G. Murphy et al. ANTI-CANCER DRUGS
- Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
- (2012) Yung-Jue Bang JOURNAL OF CLINICAL GASTROENTEROLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
- (2012) H. Greulich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
- (2012) Ron Bose et al. Cancer Discovery
- Different HER2 Protein Expression Profiles Aid in the Histologic Differential Diagnosis Between Urothelial Carcinoma In Situ (CIS) and Non-CIS Conditions (Dysplasia and Reactive Atypia) of the Urinary Bladder Mucosa
- (2011) Sven Gunia et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours
- (2011) Achim Fleischmann et al. EUROPEAN UROLOGY
- Clinical Notice for American Society of Clinical Oncology-College of American Pathologists Guideline Recommendations on ER/PgR and HER2 Testing in Breast Cancer
- (2011) M. Elizabeth Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib
- (2011) Rama Krishna Kancha et al. PLoS One
- HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladder
- (2011) Hans Olsson et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- Role of anti-Her-2 therapy in bladder carcinoma
- (2010) Álvaro Pinto Marín et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients
- (2009) M. Lae et al. ANNALS OF ONCOLOGY
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma
- (2009) Christian Wülfing et al. CANCER
- Role of Polysomy 17 in Transitional Cell Carcinoma of the Bladder: Immunohistochemical Study of HER2/neu Expression and FISH Analysis of c-erbB-2 Gene and Chromosome 17
- (2009) Sara Simonetti et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
- (2009) Guido Sauter et al. JOURNAL OF CLINICAL ONCOLOGY
- No Strong Association Between HER-2/neu Protein Overexpression and Gene Amplification in High-grade Invasive Urothelial Carcinomas
- (2009) Vildan Caner et al. PATHOLOGY & ONCOLOGY RESEARCH
- Optimizing therapeutic strategies in advanced bladder cancer: Update on chemotherapy and the role of targeted agents
- (2008) J. Bellmunt et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More